Abstract
To the Editor. — JAMA 's 500-word limit for Letters to the Editor is insufficient to address the incomplete understanding of the breast cancer screening trials that has characterized recent analyses of the data and the recent Editorial by Drs Davis and Love. 1 The authors stated mammographic screening in women under 50 years of age does not reduce deaths. This is simply not true. They based their conclusions about screening on a meta-analysis that used outdated information. The Gothenburg trial 2 recently revealed a 40% decrease in breast cancer deaths for screened women aged 40 to 49 years whose cancers were detected in their 40s and not, as some have suggested, because they had reached the magical age of 50 years. The preliminary results of a new meta-analysis of the seven trials with similar design demonstrate a statistically significant mortality reduction (at the 95% confidence level using a two-tailed
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: JAMA: The Journal of the American Medical Association
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
